论文部分内容阅读
目的:观察益生菌在治疗小儿抗生素相关性腹泻(AAD)方面的临床疗效。方法:收集我院2015年1-6月因小儿肺炎治疗临床应用抗生素治疗后并发腹泻的患儿病例82例,随机分为对照组(40例)和益生菌治疗组(42例),所有病例均给予口服蒙脱石散做基础治疗,治疗组口服枯草杆菌肠球菌二联活菌颗粒(妈咪爱),比较两组临床疗效,结果:益生菌治疗组临床疗效优于对照组,腹泻症状缓解时间明显比对照组短。结论益生菌能治疗小儿抗生素相关性腹泻的疗效较好,没有不良反应,值得临床推广。
Objective: To observe the clinical efficacy of probiotics in the treatment of pediatric antibiotic-associated diarrhea (AAD). Methods: A total of 82 cases of children with diarrhea after clinical antibiotics treatment in children with pneumonia in our hospital from January to June 2015 were randomly divided into control group (40 cases) and probiotics treatment group (42 cases), and all cases Were given oral montmorillonite powder to do the basic treatment, the treatment group oral Bacillus subtilis Enterobacter double viable particles (Mommy love), the clinical efficacy of the two groups were compared, the results: the clinical efficacy of probiotics treatment group was better than the control group, diarrhea The remission time was significantly shorter than that of the control group. Conclusion Probiotics can treat pediatric antibiotic-associated diarrhea with good efficacy and no adverse reactions, which is worthy of clinical promotion.